Chapter 14 Equine Herpesviruses

  1. Allen GP, Bryans JT: Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Prog Vet Microbiol Immunol 2:78–144, 1986. PUBMED Abstract
  2. Bryans JT, Allen GP: Herpesviral diseases of the horse. In Wittmann GE, editor: Herpesviral diseases of cattle, horses and pigs, Boston, 1989, Kluwer, pp 176–229.
  3. Allen GP, Kydd JK, Slater JD, et al: Advances in understanding of the epidemiology, pathogenesis and immunological control of equid herpesvirus-1 abortion. In Wernery U, Wade J, Mumford J, et al, editors: Equine infectious diseases VIII, Newmarket, Suffolk, UK, 1999, R&W Publications.
  4. Patel JR, Heldens J: Equine herpesviruses 1 (EHV-1) and 4 (EHV-4): epidemiology, disease and immunoprophylaxis: a brief review. Vet J 170(1):14–23, 2005. PUBMED Abstract
  5. Borchers K, Frolich K, Ludwig H: Detection of equine herpesvirus types 2 and 5 (EHV-2 and EHV-5) in Przewalski's wild horses. Arch Virol 144(4):771–780, 1999. PUBMED Abstract
  6. Borchers K, Wiik H, Frolich K, et al: Antibodies against equine herpesviruses and equine arteritis virus in Burchell's zebras (Equus burchelli) from the Serengeti ecosystem. J Wildl Dis 41(1):80–86, 2005. PUBMED Abstract
  7. Borchers K, Frolich K: Antibodies against equine herpesviruses in free-ranging mountain zebras from Namibia. J Wildl Dis 33(4):812–817, 1997. PUBMED Abstract
  8. Wolff PL, Meehan TP, Basgall EJ, et al: Abortion and perinatal foal mortality associated with equine herpesvirus type 1 in a herd of Grevy's zebra. J Am Vet Med Assoc 189(9):1185–1186, 1986. PUBMED Abstract
  9. Montali RJ, Allen GP, Bryans JT, et al: Equine herpesvirus type 1 abortion in an onager and suspected herpesvirus myelitis in a zebra. J Am Vet Med Assoc 187(11):1248–1249, 1985. PUBMED Abstract
  10. Marenzoni ML, Passamonti F, Lepri E, et al: Quantification of Equid herpesvirus 5 DNA in clinical and necropsy specimens collected from a horse with equine multinodular pulmonary fibrosis. J Vet Diagn Invest 23:802–806, 2011. PUBMED Abstract
  11. Soare T, Leeming G, Morgan R, et al: Equine multinodular pulmonary fibrosis in horses in the UK. Vet Rec 169:313, 2011. PUBMED Abstract
  12. Williams KJ, Maes R, Del Piero F, et al: Equine multinodular pulmonary fibrosis: a newly recognized herpesvirus-associated fibrotic lung disease. Vet Pathol 44:849–862, 2007. PUBMED Abstract
  13. Giles RC, Donahue JM, Hong CB, et al: Causes of abortion, stillbirth, and perinatal death in horses: 3,527 cases (1986-1991). J Am Vet Med Assoc 203(8):1170–1175, 1993. PUBMED Abstract
  14. Hong CB, Donahue JM, Giles RC, et al: Equine abortion and stillbirth in central Kentucky during 1988 and 1989 foaling seasons. J Vet Diagn Invest 5(4):560–566, 1993. PUBMED Abstract
  15. Murray MJ, Del Piero F, Jeffrey SC, et al: Neonatal equine herpesvirus type 1 infection on a thoroughbred breeding farm. J Vet Intern Med 12(1):36–41, 1998. PUBMED Abstract
  16. Dimock WW: The diagnosis of virus abortion in mares. J Am Vet Med Assoc 96:665–666, 1940.
  17. Dimock WW, Edwards PR, Bruner DW: Infections observed in equine fetuses and foals. Cornell Vet 37:90–99, 1947. PUBMED Abstract
  18. Doll ER, Bryans JT: Epizootiology of equine viral rhinopneumonitis. J Am Vet Med Assoc 142:31–37, 1963. PUBMED Abstract
  19. Martens JG, Martens RJ, Crandall RA, et al: Molecular confirmation of an abortigenic strain of equine herpesvirus 1 (subtype 1) in a pregnant mare study. Cornell Vet 79(4):363–371, 1989. PUBMED Abstract
  20. Cullinane AA, Rixon FJ, Davison AJ: Characterization of the genome of equine herpesvirus 1 subtype 2. J Gen Virol 69(pt 7):1575–1590, 1988. PUBMED Abstract
  21. Coignoul FL, Bertram TA, Cheville NF: Pathogenicity of equine herpesvirus 1 subtype 2 for foals and adult pony mares. Vet Microbiol 9(6):533–542, 1984. PUBMED Abstract
  22. Allen GP, Turtinen LW: Assessment of the base sequence homology between the two subtypes of equine herpesvirus 1. J Virol 44(1):249–255, 1982. PUBMED Abstract
  23. Studdert MJ: Differentiation of subtypes within equine herpesvirus type 1. Aust Vet J 56(1):45, 1980. PUBMED Abstract
  24. Lunn DP, Davis-Poynter N, Flaminio MJ, et al: Equine herpesvirus-1 consensus statement. J Vet Int Med 23:450–461, 2009. PUBMED Abstract
  25. Doll ER, Bryans JT: Immunization of young horses against viral rhinopneumonitis. Cornell Vet 53:24–41, 1963. PUBMED Abstract
  26. Kydd JH, Wattrang E, Hannant D: Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares. Vet Immunol Immunopathol 96(3-4):207–217, 2003. PUBMED Abstract
  27. Soboll G, Whalley JM, Koen MT, et al: Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes. J Gen Virol 84(pt 10):2625–2634, 2003. PUBMED Abstract
  28. Paillot R, Ellis SA, Daly JM, et al: Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection. Vaccine 24:1490–1500, 2006. PUBMED Abstract
  29. Roizman B, Desrosiers RC, Fleckenstein B, et al: Herpesviridae. In Murray FA, et al, editors: Sixth Report of the International Committee on Taxonomy of Viruses, New York, 1995, Springer-Verlag, pp 114–127.
  30. Allen GP, O'Callaghan DJ, Randall CC: Genetic relatedness of equine herpesvirus types 1 and 3. J Virol 24(3):761–767, 1977. PUBMED Abstract
  31. Patel JR, Edington N: The pathogenicity in mice of respiratory, abortion and paresis isolates of equine herpesvirus-1. Vet Microbiol 8(3):301–305, 1983. PUBMED Abstract
  32. Awan AR, Chong YC, Field HJ: The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. J Gen Virol 71(pt 5):1131–1140, 1990. PUBMED Abstract
  33. Awan AR, Gibson JS, Field HJ: A murine model for studying EHV-1-induced abortion. Res Vet Sci 51(1):94–99, 1991. PUBMED Abstract
  34. Iqbal J, Edington N: Equid herpesvirus 1 is neurotropic in mice, but latency from which infectious virus can be reactivated does not occur. Acta Vet Hung 50(1):117–129, 2002. PUBMED Abstract
  35. Burek JD, Roos RP, Narayan O: Virus-induced abortion: studies of equine herpesvirus 1 (abortion virus) in hamsters. Lab Invest 33(4):400–406, 1975. PUBMED Abstract
  36. Stokes A, Allen GP, Pullen LA, et al: A hamster model of equine herpesvirus type 1 (EHV-1) infection: passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18. J Gen Virol 70(pt 5):1173–1183, 1989. PUBMED Abstract
  37. Tearle JP, Smith KC, Platt AJ, et al: In vitro characterisation of high and low virulence isolates of equine herpesvirus-1 and -4. Res Vet Sci 75(1):83–86, 2003. PUBMED Abstract
  38. Kydd JH, Smith KC, Hannant D, et al: Distribution of equid herpesvirus-1 (EHV-1) in the respiratory tract of ponies: implications for vaccination strategies. Equine Vet J 26:466–469, 1994. PUBMED Abstract
  39. Smith DJ, Hamblin AS, Edington N: Infection of endothelial cells with equine herpesvirus-1 (EHV-1) occurs where there is activation of putative adhesion molecules: a mechanism for transfer of virus. Equine Vet J 33(2):138–142, 2001. PUBMED Abstract
  40. Slater JD, Borchers K, Thackray AM, et al: The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse. J Gen Virol 75(pt 8):2007–2016, 1994. PUBMED Abstract
  41. Kydd JH, Smith KC, Hannant D, et al: Distribution of equid herpesvirus-1 in the respiratory tract–associated lymphoid tissue: implications for cellular immunity. Equine Vet J 26:470–473, 1994. PUBMED Abstract
  42. Paillot R, Daly JM, Juillard V, et al: Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1. Vaccine 23(36):4541–4551, 2005. PUBMED Abstract
  43. Collinson PN, O'Rielly JL, Ficorilli N, et al: Isolation of equine herpesvirus type 2 (equine gammaherpesvirus 2) from foals with keratoconjunctivitis. J Am Vet Med Assoc 205(2):329–331, 1994. PUBMED Abstract
  44. Borchers K, Wolfinger U, Goltz M, et al: Distribution and relevance of equine herpesvirus type 2 (EHV-2) infections. Arch Virol 142(5):917–928, 1997. PUBMED Abstract
  45. Rizvi SM, Slater JD, Wolfinger U, et al: Detection and distribution of equine herpesvirus 2 DNA in the central and peripheral nervous systems of ponies. J Gen Virol 78(pt 5):1115–1118, 1997. PUBMED Abstract
  46. Telford EA, Watson MS, Aird HC, et al: The DNA sequence of equine herpesvirus 2. J Mol Biol 249(3):520–528, 1995. PUBMED Abstract
  47. Telford EA, Watson MS, McBride K, et al: The DNA sequence of equine herpesvirus-1. Virology 189(1):304–316, 1992. PUBMED Abstract
  48. Telford EA, Watson MJ, Perry J, et al: The DNA sequence of equine herpesvirus-4. J Gen Virol 79(pt 5):1197–1203, 1998. PUBMED Abstract
  49. Rudolph J, O'Callaghan DJ, Osterrieder N: Cloning of the genomes of equine herpesvirus type 1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC). J Vet Med B Infect Dis Vet Public Health 49(1):31–36, 2002. PUBMED Abstract
  50. Rudolph J, Osterrieder N: Equine herpesvirus type 1 devoid of gM and gp2 is severely impaired in virus egress but not direct cell-to-cell spread. Virology 293(2):356–367, 2002. PUBMED Abstract
  51. Yao H, Osterrieder N, O'Callaghan DJ: Generation and characterization of an EICP0 null mutant of equine herpesvirus 1. Virus Res 98(2):163–172, 2003. PUBMED Abstract
  52. Marshall KR, Field HJ: Demonstration of equine herpesvirus-1 neuronal latency in murine olfactory bulbs using a novel combined in situ PCR and protein synthesis method. Virology 229(1):279–282, 1997. PUBMED Abstract
  53. Huang JA, Ficorilli N, Hartley CA, et al: Polymorphism of open reading frame 71 of equine herpesvirus-4 (EHV-4) and EHV-1. J Gen Virol 83(pt 3):525–531, 2002. PUBMED Abstract
  54. Caughman GB, Staczek J, O'Callaghan DJ: Equine herpesvirus type 1 infected cell polypeptides: evidence for immediate early/early/late regulation of viral gene expression. Virology 145(1):49–61, 1985. PUBMED Abstract
  55. Lewis JB, Thompson YG, Caughman GB: Transcriptional control of the equine herpesvirus 1 immediate early gene. Virology 197(2):788–792, 1993. PUBMED Abstract
  56. Albrecht RA, Kim SK, O'Callaghan DJ: The EICP27 protein of equine herpesvirus 1 is recruited to viral promoters by its interaction with the immediate-early protein. Virology 333(1):74–87, 2005. PUBMED Abstract
  57. Kim SK, O'Callaghan DJ: Molecular characterizations of the equine herpesvirus 1 ETIF promoter region and translation initiation site. Virology 286(1):237–247, 2001. PUBMED Abstract
  58. Baxi MK, Efstathiou S, Lawrence G, et al: The detection of latency-associated transcripts of equine herpesvirus 1 in ganglionic neurons. J Gen Virol 76(pt 12):3113–3118, 1995. PUBMED Abstract
  59. Chesters PM, Allsop R, Purewal A, et al: Detection of latency-associated transcripts of equid herpesvirus 1 in equine leukocytes but not in trigeminal ganglia. J Virol 71(5):3437–3443, 1997. PUBMED Abstract
  60. Borchers K, Wolfinger U, Ludwig H: Latency-associated transcripts of equine herpesvirus type 4 in trigeminal ganglia of naturally infected horses. J Gen Virol 80(pt 8):2165–2171, 1999. PUBMED Abstract
  61. Edington N, Welch HM, Griffiths L: The prevalence of latent equid herpesviruses in the tissues of 40 abattoir horses. Equine Vet J 26(2):140–142, 1994. PUBMED Abstract
  62. Welch HM, Bridges CG, Lyon AM, et al: Latent equid herpesviruses 1 and 4: detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissues. J Gen Virol 73(pt 2):261–268, 1992. PUBMED Abstract
  63. Smith DJ, Iqbal J, Purewal A, et al: In vitro reactivation of latent equid herpesvirus-1 from CD5+/CD8+ leukocytes indirectly by IL-2 or chorionic gonadotrophin. J Gen Virol 79(pt 12):2997–3004, 1998. PUBMED Abstract
  64. Edington N, Bridges CG, Huckle A: Experimental reactivation of equid herpesvirus 1 (EHV 1) following the administration of corticosteroids. Equine Vet J 17:369–372, 1985. PUBMED Abstract
  65. Purewal AS, Smallwood AV, Kaushal A, et al: Identification and control of the cis-acting elements of the immediate early gene of equid herpesvirus type 1. J Gen Virol 73(pt 3):513–519, 1992. PUBMED Abstract
  66. Burrows RG: Studies of persistent and latent equid herpesvirus-1 and herpesvirus-3 infections in the Pirbright pony herd. In Wittmann GE, Gaskell RM, Rziha HJ, editors: Latent herpesvirus infections in veterinary medicine, The Hague, 1984, Martinus Nijhoff, pp 307–319.
  67. Perdue ML, Kemp MC, Randall CC, et al: Studies of the molecular anatomy of the L-M cell strain of equine herpes virus type 1: proteins of the nucleocapsid and intact virion. Virology 59(1):201–216, 1974. PUBMED Abstract
  68. Purewal AS, Allsopp R, Riggio M, et al: Equid herpesviruses 1 and 4 encode functional homologs of the herpes simplex virus type 1 virion transactivator protein, VP16. Virology 198(1):385–389, 1994. PUBMED Abstract
  69. McLauchlan J, Rixon FJ: Characterization of enveloped tegument structures (L particles) produced by alphaherpesviruses: integrity of the tegument does not depend on the presence of capsid or envelope. J Gen Virol 73(pt 2):269–276, 1992. PUBMED Abstract
  70. Turtinen LW, Allen GP: Identification of the envelope surface glycoproteins of equine herpesvirus type 1. J Gen Virol 63(2):481–485, 1982. PUBMED Abstract
  71. Donofrio G, Cavirani S, Taddei S, et al: Activation of bovine herpesvirus 4 lytic replication in a non-permissive cell line by overexpression of BoHV-4 immediate early (IE) 2 gene. J Virol Methods 116(2):203–207, 2004. PUBMED Abstract
  72. Johnson MA, Prideaux CT, Kongsuwan K, et al: ICP27 immediate early gene, glycoprotein K (gK) and DNA helicase homologues of infectious laryngotracheitis virus (gallid herpesvirus 1) SA-2 strain. Arch Virol 140(4):623–634, 1995. PUBMED Abstract
  73. Kawaguchi Y, Maeda K, Miyazawa T, et al: Nucleotide sequence and characterization of the feline herpesvirus type 1 immediate early gene. Virology 204(1):430–435, 1994. PUBMED Abstract
  74. Grundy FJ, Baumann RP, O'Callaghan DJ: DNA sequence and comparative analyses of the equine herpesvirus type 1 immediate early gene. Virology 172(1):223–236, 1989. PUBMED Abstract
  75. Robertson AT, Caughman GB, Gray WL, et al: Analysis of the in vitro translation products of the equine herpesvirus type 1 immediate early mRNA. Virology 166(2):451–462, 1988. PUBMED Abstract
  76. Caughman GB, Robertson AT, Gray WL, et al: Characterization of equine herpesvirus type 1 immediate early proteins. Virology 163(2):563–571, 1988. PUBMED Abstract
  77. Gray WL, Baumann RT, Robertson AT, et al: Characterization and mapping of equine herpesvirus type 1 immediate early, early, and late transcripts. Virus Res 8(3):233–244, 1987. PUBMED Abstract
  78. Gray WL, Baumann RP, Robertson AT, et al: Regulation of equine herpesvirus type 1 gene expression: characterization of immediate early, early, and late transcription. Virology 158(1):79–87, 1987. PUBMED Abstract
  79. Soboll G, Breathnach CC, Kydd JH, et al: Vaccination of ponies with the IE gene of EHV-1 in a recombinant modified live vaccinia vector protects against clinical and virological disease. Vet Immunol Immunopathol 135:108–117, 2010. PUBMED Abstract
  80. Kydd JH, Davis-Poynter NJ, Birch J, et al: A molecular approach to the identification of cytotoxic T-lymphocyte epitopes within equine herpesvirus 1. J Gen Virol 87:2507–2515, 2006. PUBMED Abstract
  81. Smith RH, Caughman GB, O'Callaghan DJ: Characterization of the regulatory functions of the equine herpesvirus 1 immediate-early gene product. J Virol 66(2):936–945, 1992. PUBMED Abstract
  82. Albrecht RA, Jang HK, Kim SK, et al: Direct interaction of TFIIB and the IE protein of equine herpesvirus 1 is required for maximal trans-activation function. Virology 316(2):302–312, 2003. PUBMED Abstract
  83. Kim SK, Jang HK, Albrecht RA, et al: Interaction of the equine herpesvirus 1 EICP0 protein with the immediate-early (IE) protein, TFIIB, and TBP may mediate the antagonism between the IE and EICP0 proteins. J Virol 77(4):2675–2685, 2003. PUBMED Abstract
  84. Jang HK, Albrecht RA, Buczynski KA, et al: Mapping the sequences that mediate interaction of the equine herpesvirus 1 immediate-early protein and human TFIIB. J Virol 75(21):10219–10230, 2001. PUBMED Abstract
  85. Bowles DE, Holden VR, Zhao Y, et al: The ICP0 protein of equine herpesvirus 1 is an early protein that independently transactivates expression of all classes of viral promoters. J Virol 71(7):4904–4914, 1997. PUBMED Abstract
  86. Kim SK, Holden VR, O'Callaghan DJ: The ICP22 protein of equine herpesvirus 1 cooperates with the IE protein to regulate viral gene expression. J Virol 71(2):1004–1012, 1997. PUBMED Abstract
  87. Derbigny WA, Kim SK, Caughman DJ, et al: The EICP22 protein of equine herpesvirus 1 physically interacts with the immediate-early protein and with itself to form dimers and higher-order complexes. J Virol 74(3):1425–1435, 2000. PUBMED Abstract
  88. Bowles DE, Kim SK, O'Callaghan DJ: Characterization of the trans-activation properties of equine herpesvirus 1 EICP0 protein. J Virol 74(3):1200–1208, 2000. PUBMED Abstract
  89. Kim SK, Albrecht RA, O'Callaghan DJ: A negative regulatory element (base pairs -204 to -177) of the EICP0 promoter of equine herpesvirus 1 abolishes the EICP0 protein's trans-activation of its own promoter. J Virol 78(21):11696–11706, 2004. PUBMED Abstract
  90. Albrecht RA, Kim SK, Zhang Y, et al: The equine herpesvirus 1 EICP27 protein enhances gene expression via an interaction with TATA box-binding protein. Virology 324(2):311–326, 2004. PUBMED Abstract
  91. Derbigny WA, Kim SK, Zhang HK, et al: EHV-1 EICP22 protein sequences that mediate its physical interaction with the immediate-early protein are not sufficient to enhance the trans-activation activity of the IE protein. Virus Res 84(1-2):1–15, 2002. PUBMED Abstract
  92. Lewis JB, Thompson YG, Feng X, et al: Structural and antigenic identification of the ORF12 protein (alpha TIF) of equine herpesvirus 1. Virology 230(2):369–375, 1997. PUBMED Abstract
  93. Turtinen LW, Allen GP, Darlington RW, et al: Serologic and molecular comparisons of several equine herpesvirus type 1 strains. Am J Vet Res 42(12):2099–2104, 1981. PUBMED Abstract
  94. Azab W, Tsujimura K, Maeda K, et al: Glycoprotein C of equine herpesvirus 4 plays a role in viral binding to cell surface heparan sulfate. Virus Res 151:1–9, 2010. PUBMED Abstract
  95. Azab W, Osterrieder N: Glycoproteins D of equine herpesvirus type 1 (EHV-1) and EHV-4 determine cellular tropism independently of integrins. J Virol 86:2031–2044, 2012. PUBMED Abstract
  96. Sasaki M, Hasebe R, Makino Y, et al: Equine major histocompatibility complex class I molecules act as entry receptors that bind to equine herpesvirus-1 glycoprotein D. Genes to Cells 16:343–357, 2011. PUBMED Abstract
  97. Van de Walle GR, Peters ST, VanderVen BC, et al: Equine herpesvirus 1 entry via endocytosis is facilitated by alphaV integrins and an RSD motif in glycoprotein D. J Virol 82:11859–11868, 2008. PUBMED Abstract
  98. Meredith DM, Stocks JM, Whittaker GR, et al: Identification of the gB homologues of equine herpesvirus types 1 and 4 as disulphide-linked heterodimers and their characterization using monoclonal antibodies. J Gen Virol 70(pt 5):1161–1172, 1989. PUBMED Abstract
  99. Riggio MP, Cullinane AA, Onions DE: Identification and nucleotide sequence of the glycoprotein gB gene of equine herpesvirus 4. J Virol 63(3):1123–1133, 1989. PUBMED Abstract
  100. Whalley JM, Robertson GR, Scott NA, et al: Identification and nucleotide sequence of a gene in equine herpesvirus 1 analogous to the herpes simplex virus gene encoding the major envelope glycoprotein gB. J Gen Virol 70(pt 2):383–394, 1989. PUBMED Abstract
  101. Packiarajah P, Walker C, Gilkerson J, et al: Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice. Vet Microbiol 61(4):261–278, 1998. PUBMED Abstract
  102. Neubauer A, Braun B, Brandmuller C, et al: Analysis of the contributions of the equine herpesvirus 1 glycoprotein gB homolog to virus entry and direct cell-to-cell spread. Virology 227(2):281–294, 1997. PUBMED Abstract
  103. Osterrieder N, Wagner R, Brandmuller C, et al: Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Virology 208(2):500–510, 1995. PUBMED Abstract
  104. Willemse MJ, Chalmers WS, Cronenberg AM, et al: The gene downstream of the gC homologue in feline herpes virus type 1 is involved in the expression of virulence. J Gen Virol 75(pt 11):3107–3116, 1994. PUBMED Abstract
  105. Nicolson L, Onions DE: The nucleotide sequence of the equine herpesvirus 4 gC gene homologue. Virology 179(1):378–387, 1990. PUBMED Abstract
  106. Csellner H, Walker C, Wellington JE, et al: EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice. Arch Virol 145(11):2371–2385, 2000. PUBMED Abstract
  107. Zhang Y, Smith PM, Tarbet EB, et al: Protective immunity against equine herpesvirus type-1 (EHV-1) infection in mice induced by recombinant EHV-1 gD. Virus Res 56(1):11–24, 1998. PUBMED Abstract
  108. Maeda K, Kawaguchi Y, Ono M, et al: A gD homologous gene of feline herpesvirus type 1 encodes a hemagglutinin (gp60). Virology 202(2):1034–1038, 1994. PUBMED Abstract
  109. Cullinane AA, Neilan J, Wilson L, et al: The DNA sequence of the equine herpesvirus 4 gene encoding glycoprotein gp17/18, the homologue of herpes simplex virus glycoprotein gD. J Gen Virol 74(pt 9):1959–1564, 1993. PUBMED Abstract
  110. Tsujimura K, Shiose T, Yamanaka T, et al: Equine herpesvirus type 1 mutant defective in glycoprotein E gene as candidate vaccine strain. J Vet Med Sci 71:1439–1448, 2009. PUBMED Abstract
  111. Thormann N, Van de Walle GR, Azab W, et al: The role of secreted glycoprotein G of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in immune modulation and virulence. Virus Res 169:203–211, 2012. PUBMED Abstract
  112. Azab W, Zajic L, Osterrieder N: The role of glycoprotein H of equine herpesviruses 1 and 4 (EHV-1 and EHV-4) in cellular host range and integrin binding. Vet Res 43:61, 2012. PUBMED Abstract
  113. Stokes A, Cameron RS, Marshall RN, et al: High level expression of equine herpesvirus 1 glycoproteins D and H and their role in protection against virus challenge in the C3H (H-2Kk) murine model. Virus Res 50(2):159–173, 1997. PUBMED Abstract
  114. Maeda K, Mizukoshi F, Hamano M, et al: Identification of another B-cell epitope in the type-specific region of equine herpesvirus 4 glycoprotein G. Clin Diagn Lab Immunol 12:122–124, 2005. PUBMED Abstract
  115. Studdert MJ, Hartley CA, Dynon K, et al: Outbreak of equine herpesvirus type 1 myeloencephalitis: new insights from virus identification by PCR and the application of an EHV-1-specific antibody detection ELISA. Vet Rec 153:417–423, 2003. PUBMED Abstract
  116. Foote CE, Love DN, Gilkerson JR, et al: Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals. Vet Immunol Immunopathol 105:47–57, 2005. PUBMED Abstract
  117. Doll ER, McCollum WH, Bryans JT, et al: Effect of physical and chemical environment on the viability of equine rhinopneumonitis virus propagated in hamsters. Cornell Vet 49:75–81, 1959. PUBMED Abstract
  118. Gilkerson JR, Love DN, Drummer HE, et al: Seroprevalence of equine herpesvirus 1 in thoroughbred foals before and after weaning. Aust Vet J 76(10):677–682, 1998. PUBMED Abstract
  119. Gilkerson JR, Love DN, Whalley JM: Incidence of equine herpesvirus 1 infection in thoroughbred weanlings on two stud farms. Aust Vet J 78(4):277–278, 2000. PUBMED Abstract
  120. Gilkerson JR, Walley JM, Drummer HE, et al: Epidemiological studies of equine herpesvirus 1 (EHV-1) in Thoroughbred foals: a review of studies conducted in the Hunter Valley of New South Wales between 1995 and 1997. Vet Microbiol 68(1-2):15–25, 1999. PUBMED Abstract
  121. Foote CE, Love DN, Gilkerson JR, et al: Detection of EHV-1 and EHV-4 DNA in unweaned Thoroughbred foals from vaccinated mares on a large stud farm. Equine Vet J 36(4):341–345, 2004. PUBMED Abstract
  122. Craig MI, Barrandeguy ME, Fernandez FM: Equine herpesvirus 2 (EHV-2) infection on thoroughbred horses in Argentina. BMC Vet Res 1(1):9, 2005. PUBMED Abstract
  123. Dunowska M, Wilks CR, Studdert MJ, et al: Equine respiratory viruses in foals in New Zealand. N Z Vet J 50(4):140–147, 2002. PUBMED Abstract
  124. Nordengrahn A, Merza M, Ros C, et al: Prevalence of equine herpesvirus types 2 and 5 in horse populations by using type-specific PCR assays. Vet Res 33(3):251–259, 2002. PUBMED Abstract
  125. Edington N, Bridges CG, Huckle A: Experimental reactivation of equid herpesvirus 1 (EHV 1) following the administration of corticosteroids. Equine Vet J 17(5):369–372, 1985. PUBMED Abstract
  126. Smith KC: Herpesviral abortion in domestic animals. Vet J 153(3):253–268, 1997. PUBMED Abstract
  127. Smith KC, Borchers K: A study of the pathogenesis of equid herpesvirus-1 (EHV-1) abortion by DNA in-situ hybridization. J Comp Pathol 125(4):304–310, 2001. PUBMED Abstract
  128. Smith KC, McGladder AJ, Binns MM, et al: Use of transabdominal ultrasound-guided amniocentesis for detection of equid herpesvirus 1-induced fetal infection in utero. Am J Vet Res 58(9):997–1002, 1997. PUBMED Abstract
  129. Smith KC, Mumford JA, Lakhani K: A comparison of equid herpesvirus-1 (EHV-1) vascular lesions in the early versus late pregnant equine uterus. J Comp Pathol 114(3):231–247, 1996. PUBMED Abstract
  130. Mumford JA: The epidemiology of equid herpesvirus abortion: a tantalizing mystery. Equine Vet J 23(2):77–78, 1991. PUBMED Abstract
  131. Van Maanen C, Willink DL, Smeenk LA, et al: An equine herpesvirus 1 (EHV1) abortion storm at a riding school. Vet Q 22(2):83–87, 2000. PUBMED Abstract
  132. Kydd JH, Smith KC, Hannant D, et al: Distribution of equid herpesvirus-1 (EHV-1) in respiratory tract associated lymphoid tissue: implications for cellular immunity. Equine Vet J 26(6):470–473, 1994. PUBMED Abstract
  133. Kydd JH, Smith KC, Hannant D, et al: Distribution of equid herpesvirus-1 (EHV-1) in the respiratory tract of ponies: implications for vaccination strategies. Equine Vet J 26(6):466–469, 1994. PUBMED Abstract
  134. Gibson JS, Slater JD, Awan AR, et al: Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation. Arch Virol 123(3-4):351–366, 1992. PUBMED Abstract
  135. Stokes A, Corteyn AH, Murray PK: Clinical signs and humoral immune response in horses following equine herpesvirus type-1 infection and their susceptibility to equine herpesvirus type-4 challenge. Res Vet Sci 51(2):141–148, 1991. PUBMED Abstract
  136. Gibson JS, Slater JD, Field HJ: The pathogenicity of Ab4p, the sequenced strain of equine herpesvirus-1, in specific pathogen-free foals. Virology 189(1):317–319, 1992. PUBMED Abstract
  137. Hussey SB, Clark R, Lunn KF, et al: Detection and quantification of equine herpesvirus-1 viremia and nasal shedding by real-time polymerase chain reaction. J Vet Diagn Invest 18:335–342, 2006. PUBMED Abstract
  138. Borchers K, Wolfinger U, Lawrenz B, et al: Equine herpesvirus 4 DNA in trigeminal ganglia of naturally infected horses detected by direct in situ PCR. J Gen Virol 78(pt 5):1109–1114, 1997. PUBMED Abstract
  139. Gerst S, Borchers K, Gower SM, et al: Detection of EHV-1 and EHV-4 in placental sections of naturally occurring EHV-1- and EHV-4-related abortions in the UK: use of the placenta in diagnosis. Equine Vet J 35(5):430–433, 2003. PUBMED Abstract
  140. Pusterla N, Leutenegger CM, Wilson WD, et al: Equine herpesvirus-4 kinetics in peripheral blood leukocytes and nasopharyngeal secretions in foals using quantitative real-time TaqMan PCR. J Vet Diagn Invest 17:578–581, 2005. PUBMED Abstract
  141. Gleeson LJ, Coggins L: Response of pregnant mares to equine herpesvirus 1 (EHV1). Cornell Vet 70(4):391–400, 1980. PUBMED Abstract
  142. McColloch J, Williamson SA, Powis SJ, et al: The effect of EHV-1 infection upon circulating leucocyte populations in the natural equine host. Vet Microbiol 37:147–161, 1993. PUBMED Abstract
  143. Slater JD, Baxi M, Tewari D, et al: Experimental infection of specific pathogen free ponies with equid herpesvirus-1: detection of infectious virus and viral DNA. In Nakajima W, editor: Equine infectious diseases VII, Newmarket, Suffolk, UK, 1994, R&W Publications, pp 255–226.
  144. Wilsterman S, Soboll-Hussey G, Lunn DP, et al: Equine herpesvirus-1 infected peripheral blood mononuclear cell subpopulations during viremia. Vet Microbiol 149:40–47, 2011. PUBMED Abstract
  145. Van der Meulen KM, Nauwynck HJ, Pensaert MB: Increased susceptibility of peripheral blood mononuclear cells to equine herpes virus type 1 infection upon mitogen stimulation: a role of the cell cycle and of cell-to-cell transmission of the virus. Vet Microbiol 86(1-2):157–163, 2002. PUBMED Abstract
  146. Allen GP, Breathnach CC: Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1. Equine Vet J 38:252–257, 2006. PUBMED Abstract
  147. Matsumura T, Sugiura T, Imagawa H, et al: Epizootiological aspects of type 1 and type 4 equine herpesvirus infections among horse populations. J Vet Med Sci 54(2):207–211, 1992. PUBMED Abstract
  148. Edington N, Smyth B, Griffiths L: The role of endothelial cell infection in the endometrium, placenta and foetus of equid herpesvirus 1 (EHV-1) abortions. J Comp Pathol 104(4):379–387, 1991. PUBMED Abstract
  149. Smith KC, Whitwell KE, Binns MM, et al: Abortion of virologically negative foetuses following experimental challenge of pregnant pony mares with equid herpesvirus 1. Equine Vet J 24(4):256–259, 1992. PUBMED Abstract
  150. Smith KC, Whitwell KE, Blunden AS, et al: Equine herpesvirus-1 abortion: atypical cases with lesions largely or wholly restricted to the placenta. Equine Vet J 36(1):79–82, 2004. PUBMED Abstract
  151. Smith KC, Whitwell KE, Mumford JA, et al: An immunohistological study of the uterus of mares following experimental infection by equid herpesvirus 1. Equine Vet J 25(1):36–40, 1993. PUBMED Abstract
  152. Gardiner DW, Lunn DP, Goehring LS, et al: Strain impact on equine herpesvirus type 1 (EHV-1) abortion models: viral loads in fetal and placental tissues and foals. Vaccine 30:6564–6572, 2012. PUBMED Abstract
  153. Smith KC, Whitwell KE, Mumford JA, et al: Virulence of the V592 isolate of equid herpesvirus-1 in ponies. J Comp Pathol 122(4):288–297, 2000. PUBMED Abstract
  154. Edington N, Bridges CG, Patel JR: Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: equine stroke. Arch Virol 90(1-2):111–124, 1986. PUBMED Abstract
  155. Goehring LS, Hussey GS, Ashton LV, et al: Infection of central nervous system endothelial cells by cell-associated EHV-1. Vet Microbiol 148:389–395, 2011. PUBMED Abstract
  156. Jackson TA, Osburn BI, Cordy DR, et al: Equine herpesvirus 1 infection of horses: studies on the experimentally induced neurologic disease. Am J Vet Res 38(6):709–719, 1977. PUBMED Abstract
  157. Schultheiss PC, Collins JK, Hotaling SF: Immunohistochemical demonstration of equine herpesvirus-1 antigen in neurons and astrocytes of horses with acute paralysis. Vet Pathol 34(1):52–54, 1997. PUBMED Abstract
  158. Schmidt P, Meyer H, Hubert P, et al: In-situ hybridization for demonstration of equine herpesvirus type 1 DNA in paraffin wax-embedded tissues and its use in horses with disseminated necrotizing myeloencephalitis. J Comp Pathol 110(3):215–225, 1994. PUBMED Abstract
  159. Nugent J, Birch-Machin I, Smith KC, et al: Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks. J Virol 80:4047–4060, 2006. PUBMED Abstract
  160. Pusterla N, Wilson WD, Mapes S, et al: Characterization of viral loads, strain and state of equine herpesvirus-1 using real-time PCR in horses following natural exposure at a racetrack in California. Vet J 179:230–239, 2009. PUBMED Abstract
  161. Allen GP, Bolin DC, Bryant U, et al: Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky. Equine Vet J 40:105–110, 2008. PUBMED Abstract
  162. Tsujimura K, Oyama T, Katayama Y, et al: Prevalence of equine herpesvirus type 1 strains of neuropathogenic genotype in a major breeding area of Japan. J Vet Med Sci 73:1663–1667, 2011. PUBMED Abstract
  163. Goodman LB, Loregian A, Perkins GA, et al: A point mutation in a herpesvirus polymerase determines neuropathogenicity. PLoS Pathog 3:e160, 2007. PUBMED Abstract
  164. Wagner B, Wimer C, Freer H, et al: Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-alpha induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains. Vet Immunol Immunopathol 143:116–124, 2011. PUBMED Abstract
  165. Perkins GA, Goodman LB, Tsujimura K, et al: Investigation of the prevalence of neurologic equine herpes virus type 1 (EHV-1) in a 23-year retrospective analysis (1984-2007). Vet Microbiol 139:375–378, 2009. PUBMED Abstract
  166. Pronost S, Legrand L, Pitel PH, et al: Outbreak of equine herpesvirus myeloencephalopathy in France: a clinical and molecular investigation. Transbound Emerg Dis 59:256–263, 2012. PUBMED Abstract
  167. Smith KL, Allen GP, Branscum AJ, et al: The increased prevalence of neuropathogenic strains of EHV-1 in equine abortions. Vet Microbiol 141:5–11, 2010. PUBMED Abstract
  168. Doll ER, Crowe ME, Bryans JT, et al: Infection immunity in equine virus abortion. Cornell Vet 45(3):387–410, 1955. PUBMED Abstract
  169. Hannant D, Jessett DM, O'Neill T, et al: Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain. Res Vet Sci 54(3):299–305, 1993. PUBMED Abstract
  170. Van der Meulen KM, Nauwynck HJ, Pensaert MB: Absence of viral antigens on the surface of equine herpesvirus-1–infected peripheral blood mononuclear cells: a strategy to avoid complement-mediated lysis. J Gen Virol 84(pt 1):93–97, 2003. PUBMED Abstract
  171. Breathnach CC, Yeargan MR, Sheoran AS, et al: The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens. Equine Vet J 33(7):651–657, 2001. PUBMED Abstract
  172. Edens LM, Crisman MV, Toth TE, et al: In vitro cytotoxic activity of equine lymphocytes on equine herpesvirus-1 infected allogenic fibroblasts. Vet Immunol Immunopathol 52(3):175–189, 1996. PUBMED Abstract
  173. Allen G, Yeargan M, Costa LR, et al: Major histocompatibility complex class I–restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. J Virol 69(1):606–612, 1995. PUBMED Abstract
  174. Wilks CR: In vitro cytotoxicity of serum and peripheral blood leukocytes for equine herpesvirus type 1–infected target cells. Am J Vet Res 38(1):117–121, 1977. PUBMED Abstract
  175. O'Neill T, Kydd JH, Allen GP, et al: Determination of equid herpesvirus 1–specific, CD8+, cytotoxic T lymphocyte precursor frequencies in ponies. Vet Immunol Immunopathol 70(1-2):43–54, 1999. PUBMED Abstract
  176. Breathnach CC, Soboll G, Suresh M, et al: Equine herpesvirus-1 infection induces IFN-gamma production by equine T lymphocyte subsets. Vet Immunol Immunopathol 103(3-4):207–215, 2005. PUBMED Abstract
  177. Coombs DK, Patton T, Kohler AK, et al: Cytokine responses to EHV-1 infection in immune and non-immune ponies. Vet Immunol Immunopathol 111:109–116, 2006. PUBMED Abstract
  178. Rappocciolo G, Birch J, Ellis SA: Down-regulation of MHC class I expression by equine herpesvirus-1. J Gen Virol 84(pt 2):293–300, 2003. PUBMED Abstract
  179. Dunowska M, Meers J, Wilks CR: Isolation of equine herpesvirus type 5 in New Zealand. N Z Vet J 47(2):44–46, 1999. PUBMED Abstract
  180. Fortier G, van Erck E, Fortier C, et al: Herpesviruses in respiratory liquids of horses: putative implication in airway inflammation and association with cytological features. Vet Microbiol 139(1-2):34–41, 2009. Epub 2009 Apr 19. PUBMED Abstract
  181. Kershaw O, von Oppen T, Glitz F, et al: Detection of equine herpesvirus type 2 (EHV-2) in horses with keratoconjunctivitis. Virus Res 80(1-2):93–99, 2001. PUBMED Abstract
  182. Léon A, Fortier G, Fortier C, et al: Detection of equine herpesviruses in aborted foetuses by consensus PCR. Vet Microbiol 126(1-3):20–29, 2008. Epub 2007 Jun 28. PUBMED Abstract
  183. Nordengrahn A, Rusvai M, Merza M, et al: Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes. Vet Microbiol 51(1-2):55–68, 1996. PUBMED Abstract
  184. Varga J, Fodor L, Rusvai M, et al: Prevention of Rhodococcus equi pneumonia of foals using two different inactivated vaccines. Vet Microbiol 56(3-4):205–212, 1997. PUBMED Abstract
  185. Fortier G, Pronost S, Miszczak F, et al: Identification of equid herpesvirus-5 in respiratory liquids: a retrospective study of 785 samples taken in 2006-2007. Vet J 182:346–348, 2009. PUBMED Abstract
  186. Wood JL, Burrell MH, Roberts CA, et al: Streptococci and Pasteurella spp. associated with disease of the equine lower respiratory tract. Equine Vet J 25(4):314–318, 1993. PUBMED Abstract
  187. Newton JR, Wood JL: Evidence of an association between inflammatory airway disease and EIPH in young Thoroughbreds during training. Equine Vet J Suppl 34:417–424, 2002. PUBMED Abstract
  188. Wood JL, Newton JR, Chanter N, et al: Inflammatory airway disease, nasal discharge and respiratory infections in young British racehorses. Equine Vet J 37(3):236–242, 2005. PUBMED Abstract
  189. Wood JL, Newton JR, Chanter N, et al: Association between respiratory disease and bacterial and viral infections in British racehorses. J Clin Microbiol 43(1):120–126, 2005. PUBMED Abstract
  190. Gibson JS, O'Neill T, Thackray A, et al: Serological responses of specific pathogen-free foals to equine herpesvirus-1: primary and secondary infection, and reactivation. Vet Microbiol 32(3-4):199–214, 1992. PUBMED Abstract
  191. Kydd JH, Hannant D, Mumford JA: Residence and recruitment of leucocytes to the equine lung after EHV-1 infection. Vet Immunol Immunopathol 52(1-2):15–26, 1996. PUBMED Abstract
  192. Goehring LS, van Maanen C, Sloet van Oldruitenborgh-Oosterbaan MM: Neurological syndromes among horses in The Netherlands: a 5 year retrospective survey (1999-2004). Vet Q 27(1):11–20, 2005. PUBMED Abstract
  193. Mumford JA, Rossdale PD, Jessett DM, et al: Serological and virological investigations of an equid herpesvirus 1 (EHV-1) abortion storm on a stud farm in 1985. J Reprod Fertil Suppl 35:509–518, 1987. PUBMED Abstract
  194. Studdert MJ, Fitzpatrick DR, Horner GW, et al: Molecular epidemiology and pathogenesis of some equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus) isolates. Aust Vet J 61(11):345–348, 1984. PUBMED Abstract
  195. O'Keefe JS, Alley MR, Jones D, et al: Neonatal mortality due to equid herpesvirus 4 (EHV-4) in a foal. Aust Vet J 72:353–354, 1995. PUBMED Abstract
  196. Walter J, Balzer HJ, Seeh C, et al: Venereal shedding of equid herpesvirus-1 (EHV-1) in naturally infected stallions. J Vet Intern Med 26:1500–1504, 2012. PUBMED Abstract
  197. Smith KC, Tearle JP, Boyle MS, et al: Replication of equid herpesvirus-1 in the vaginal tunics of colts following local inoculation. Res Vet Sci 54(2):249–251, 1993. PUBMED Abstract
  198. Tearle JP, Smith KC, Boyle MS, et al: Replication of equid herpesvirus-1 (EHV-1) in the testes and epididymides of ponies and venereal shedding of infectious virus. J Comp Pathol 115(4):385–397, 1996. PUBMED Abstract
  199. Kohn CW, Fenner WR: Equine herpes myeloencephalopathy. Vet Clin North Am Equine Pract 3:405–419, 1987. PUBMED Abstract
  200. Jackson T, Kendrick JW: Paralysis of horses associated with equine herpesvirus 1 infection. J Am Vet Med Assoc 158(8):1351–1357, 1971. PUBMED Abstract
  201. Studdert MJ, Hartley CA, Dynon K, et al: Outbreak of equine herpesvirus type 1 myeloencephalitis: new insights from virus identification by PCR and the application of an EHV-1-specific antibody detection ELISA. Vet Rec 153(14):417–423, 2003. PUBMED Abstract
  202. Greenwood RE, Simson AR: Clinical report of a paralytic syndrome affecting stallions, mares and foals on a Thoroughbred studfarm. Equine Vet J 12(3):113–117, 1980. PUBMED Abstract
  203. Burgess BA, Tokateloff N, Manning S, et al: Nasal shedding of equine herpesvirus-1 from horses in an outbreak of equine herpes myeloencephalopathy in Western Canada. J Vet Intern Med 26:384–392, 2012. PUBMED Abstract
  204. Henninger RW, Reed SM, Saville WJ, et al: Outbreak of neurologic disease caused by equine herpesvirus-1 at a university equestrian center. J Vet Intern Med 21:157–165, 2007. PUBMED Abstract
  205. Goehring LS, Landolt GA, Morley PS: Detection and management of an outbreak of equine herpesvirus type 1 infection and associated neurological disease in a veterinary teaching hospital. J Vet Intern Med 24:1176–1183, 2010. PUBMED Abstract
  206. Pusterla N, Wilson WD, Madigan JE, et al: Equine herpesvirus-1 myeloencephalopathy: a review of recent developments. Vet J 180:279–289, 2009. PUBMED Abstract
  207. McCartan CG, Russell MM, Wood JL, et al: Clinical, serological and virological characteristics of an outbreak of paresis and neonatal foal disease due to equine herpesvirus-1 on a stud farm. Vet Rec 136(1):7–12, 1995. PUBMED Abstract
  208. Friday PA, Scarratt WK, Elvinger F, et al: Ataxia and paresis with equine herpesvirus type 1 infection in a herd of riding school horses. J Vet Intern Med 14(2):197–201, 2000. PUBMED Abstract
  209. Van Maanen C, Sloet van Oldruitenborgh-Oosterbaan MM, Damen EA, et al: Neurological disease associated with EHV-1-infection in a riding school: clinical and virological characteristics. Equine Vet J 33(2):191–196, 2001. PUBMED Abstract
  210. Daly P, Doyle S: The development of a competitive PCR-ELISA for the detection of equine herpesvirus-1. J Virol Methods 107(2):237–244, 2003. PUBMED Abstract
  211. Druce J, Catton M, Chibo D, et al: Utility of a multiplex PCR assay for detecting herpesvirus DNA in clinical samples. J Clin Microbiol 40(5):1728–1732, 2002. PUBMED Abstract
  212. Carvalho R, Passos LM, Martins AS: Development of a differential multiplex PCR assay for equine herpesvirus 1 and 4 as a diagnostic tool. J Vet Med B Infect Dis Vet Public Health 47(5):351–359, 2000. PUBMED Abstract
  213. Moore S, Gunn M, Walls D: A rapid and sensitive PCR-based diagnostic assay to detect bovine herpesvirus 1 in routine diagnostic submissions. Vet Microbiol 75(2):145–153, 2000. PUBMED Abstract
  214. Ehlers B, Borchers K, Grund C, et al: Detection of new DNA polymerase genes of known and potentially novel herpesviruses by PCR with degenerate and deoxyinosine-substituted primers. Virus Genes 18(3):211–220, 1999. PUBMED Abstract
  215. McCann SH, Mumford JA, Binns MM: Development of PCR assays to detect genetic variation amongst equine herpesvirus-1 isolates as an aid to epidemiological investigation. J Virol Methods 52(1-2):183–194, 1995. PUBMED Abstract
  216. Osterrieder N, Hubert PH, Brandmuller C, et al: A touchdown PCR for the differentiation of equine herpesvirus type 1 (EHV-1) field strains from the modified live vaccine strain RacH. J Virol Methods 50(1-3):129–136, 1994. PUBMED Abstract
  217. Edington N, Welch HM, Griffiths L: The prevalence of latent equid herpesviruses in the tissues of 40 abattoir horses. Equine Vet J 26:140–142, 1994. PUBMED Abstract
  218. Borchers K, Slater J: A nested PCR for the detection and differentiation of EHV-1 and EHV-4. J Virol Methods 45(3):331–336, 1993. PUBMED Abstract
  219. Perkins GA, Goodman LB, Dubovi EJ, et al: Detection of equine herpesvirus-1 in nasal swabs of horses by quantitative real-time PCR. J Vet Intern Med 22:1234–1238, 2008. PUBMED Abstract
  220. Pusterla N, Mapes S, Wilson WD: Diagnostic sensitivity of nasopharyngeal and nasal swabs for the molecular detection of EHV-1. Vet Rec 162:520–521, 2008. PUBMED Abstract
  221. Pusterla N, Mapes S, Wilson WD: Use of viral loads in blood and nasopharyngeal secretions for the diagnosis of EHV-1 infection in field cases. Vet Rec 162:728–729, 2008. PUBMED Abstract
  222. Pusterla N, Wilson WD, Mapes S, et al: Diagnostic evaluation of real-time PCR in the detection of Rhodococcus equi in faeces and nasopharyngeal swabs from foals with pneumonia. Vet Rec 161:272–275, 2007. PUBMED Abstract
  223. Whitwell KE, Gower SM, Smith KC: An immunoperoxidase method applied to the diagnosis of equine herpesvirus abortion, using conventional and rapid microwave techniques. Equine Vet J 24(1):10–12, 1992. PUBMED Abstract
  224. Thomson GR, Mumford JA, Campbell J, et al: Serological detection of equid herpesvirus 1 infections of the respiratory tract. Equine Vet J 8(2):58–65, 1976. PUBMED Abstract
  225. Doll ER, Wallace ME, Bryans JT, et al: Complement-fixation antibody response following administration of equine virus abortion vaccine. Am J Vet Res 14(50):46–48, 1953. PUBMED Abstract
  226. Crabb BS, MacPherson CM, Reubel GH, et al: A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1. Arch Virol 140(2):245–258, 1995. PUBMED Abstract
  227. Drummer HE, Reynolds A, Studdert MJ, et al: Application of an equine herpesvirus 1 (EHV1) type-specific ELISA to the management of an outbreak of EHV1 abortion. Vet Rec 136(23):579–581, 1995. PUBMED Abstract
  228. Hartley CA, Wilks CR, Studdert MJ, et al: Comparison of antibody detection assays for the diagnosis of equine herpesvirus 1 and 4 infections in horses. Am J Vet Res 66(5):921–928, 2005. PUBMED Abstract
  229. Reed SM, Saville WJ, Schneider RK: Neurologic disease: current topics in-depth. Paper presented at the 49th Annual Convention of the American Association of Equine Practitioners, New Orleans, 2003.
  230. Collins P: The spectrum of antiviral activities of acyclovir in vitro and in vivo. J Antimicrob Chemother 12(suppl B):19–27, 1983. PUBMED Abstract
  231. De la Fuente R, Awan AR, Field HJ: The acyclic nucleoside analogue penciclovir is a potent inhibitor of equine herpesvirus type 1 (EHV-1) in tissue culture and in a murine model. Antiviral Res 18(1):77–89, 1992. PUBMED Abstract
  232. Rollinson EA, White G: Relative activities of acyclovir and BW759 against Aujeszky's disease and equine rhinopneumonitis viruses. Antimicrob Agents Chemother 24(2):221–226, 1983. PUBMED Abstract
  233. Wilkins PA, Reed SM, Del Piero F: Acyclovir as treatment for EHV-1 myeloencephalopathy. Paper presented at the 49th Annual Convention of the American Association of Equine Practitioners, New Orleans, 2003.
  234. Garre B, van der Meulen K, Nugent J, et al: In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet. Vet Microbiol 122:43–51, 2007. PUBMED Abstract
  235. Carmichael RJ, Whitfield C, Maxwell LK: Pharmacokinetics of ganciclovir and valganciclovir in the adult horse. J Vet Pharm Ther January 10, 2013. Epub ahead of print. PUBMED Abstract
  236. Doll ER, Bryans JT: A planned infection program for immunizing mares against viral rhinopneumonitis. Cornell Vet 53:249–262, 1963. PUBMED Abstract
  237. Bentz BG, Maxwell LK, Erkert RS, et al: Pharmacokinetics of acyclovir after single intravenous and oral administration to adult horses. J Vet Intern Med 20:589–594, 2006. PUBMED Abstract
  238. Garré B, Shebany K, Gryspeerdt A, et al: Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses. Antimicrob Agents Chemother 51:4308–4314, 2007. PUBMED Abstract
  239. Maxwell LK, Bentz RG, Bourne DW, et al: Pharmacokinetics of valacyclovir in the adult horse. J Vet Pharmacol Ther 31(4):312–320, 2008. PUBMED Abstract
  240. Garré B, Gryspeerdt A, Croubels S, et al: Evaluation of orally administered valacyclovir in experimentally EHV1-infected ponies. Vet Microbiol 135:214–221, 2009. PUBMED Abstract
  241. Garré B, Baert K, Nauwynck H, et al: Multiple oral dosing of valacyclovir in horses and ponies. J Vet Pharmacol Ther 32:207–212, 2009. PUBMED Abstract
  242. Glorieux S, Vandekerckhove AP, Goris N, et al: Evaluation of the antiviral activity of (1"S,2"R)-9-[[1",2"-bis(hydroxymethyl)cycloprop-1"-yl]methyl]guanine (A-5021) against equine herpesvirus type 1 in cell monolayers and equine nasal mucosal explants. Antiviral Res 93(2):234–238, 2012. PUBMED Abstract
  243. Wong D, Scarratt WK: Equine herpes myeloencephalopathy in a 12-year-old American quarter horse. Vet Clin North Am Equine Pract 1:177–191, 2006. PUBMED Abstract
  244. Murray MJ, del Piero F, Jeffrey SC, et al: Neonatal equine herpesvirus type 1 infection on a thoroughbred breeding farm. J Vet Intern Med 12:36–41, 1998. PUBMED Abstract
  245. Bryans JT, Allen GP: Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I. Dev Biol Stand 52:493–498, 1982. PUBMED Abstract
  246. Ostlund EN: The equine herpesviruses. Vet Clin North Am Equine Pract 9:283–294, 1993. PUBMED Abstract
  247. Heldens JG, Pouwels HG, van Loon AA: Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95). Vet J 167(2):150–157, 2004. PUBMED Abstract
  248. Bresgen C, Lammer M, Wagner B, et al: Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines. Vet Microbiol 160:9–16, 2012. PUBMED Abstract
  249. Goehring LS, Wagner B, Bigbie R, et al: Control of EHV-1 viremia and nasal shedding by commercial vaccines. Vaccine 28:5203–5211, 2010. PUBMED Abstract
  250. Burrows R, Goodridge D, Denyer MS: Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus. Vet Rec 114(15):369–374, 1984. PUBMED Abstract
  251. Frymus T, Kita J, Woyciechowska S, et al: Foetal and neonatal foal losses on equine herpesvirus type 1 (EHV-1) infected farms before and after EHV-1 vaccination was introduced. Pol Arch Weter 26(3-4):7–14, 1986. PUBMED Abstract
  252. Burki F, Rossmanith W, Nowotny N, et al: Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses. Vet Q 12(2):80–86, 1990. PUBMED Abstract
  253. Burki F, Nowotny N, Oulehla J, et al: Attempts to immunoprotect adult horses, specifically pregnant mares, with commercial vaccines against clinical disease induced by equine herpesvirus-1. Zentralbl Veterinarmed B 38(6):432–440, 1991. PUBMED Abstract
  254. Bryans JT: Application of management procedures and prophylactic immunization to the control of equine rhinopneumonitis. In Proceedings of 26th Annual Convention of the American Association of Equine Practitioners, Anaheim, CA, 1981.
  255. Bryans JT, Allen GP: Control of abortigenic herpesviral infections. Curr Ther Theriogenol 2:711–714, 1986.